ly3437943 retatrutide triple agonist glp-1 gip glucagon Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds Retatrutide for Weight Loss: What
Description
Poor sleep disrupts hunger hormones (ghrelin and leptin) and can slow weight loss
The breakthrough came from creating synthetic versions of these hormones engineered to resist breakdown
Medscape website
Not all patients respond equally to GLP-1 agonist therapy, and identifying optimal candidates requires considering multiple factors, including baseline weight, comorbidities, and individual tolerance profiles
For clinicians, tirzepatide remains the evidence-based choice for current patient care
doi: 10.1002/jcb.24425 72 WangYGYangTL
